Perioperative Führung von Patienten nach Transplantationen

  • R. Scherer
  • M. Günnicker
  • J. Erhard
Conference paper
Part of the Refresher Course Aktuelles Wissen für Anästhesisten book series (REFRESHER COUR, volume 23)


Weltweit wurden 1994 z.B. an 570 Organtransplantationszentren Nierentransplantationen und an 320 Zentren Knochenmarkstranplantationen vorgenommen. Die geschätzte Gesamtzahl transplantierter Patienten in der Welt wurde auf knapp 500.000 geschätzt (Tab. 1) [1].


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Terasaki PI, Cecka JM (1994) World transplant center directory 1994. UCLA Medical School ReportGoogle Scholar
  2. 2.
    Waiting List Germany 01.07.1996. Eurotransplant Foundation InternationalGoogle Scholar
  3. 3.
    Preliminary cumulative data eurotransplant centers 31.12.1994, 31.12.1995, 30.11.1996. Eurotransplant Foundation InternationalGoogle Scholar
  4. 4.
    Terasaki PI, Cecka JM (1995) UCLA Medical School ReportGoogle Scholar
  5. 5.
    Largiadèr F, Sturm A, Wicki O (Hrg.) Checkliste Organtransplantation. Georg Thieme Verlag Stuttgart, New York, 1996Google Scholar
  6. 6.
    Lang Th (1996) Psychologie des Transplantatempfängers. In: Largiadèr F, Sturm A, Wicki O (Hrg.) Checkliste Organtransplantation. Georg Thieme Verlag Stuttgart, New York, 1996, S. 49–52Google Scholar
  7. 7.
    Minutiello L (1993) Therapeutic interruption of pregnancy in the 4th month shortly after the patient underwent heart transplantation for obstructive hypertrophic heart disease. Minerva Cardioangiol 41: 409–415PubMedGoogle Scholar
  8. 8.
    Griffith BP, Shaw BW, Hardesty RL, Iwatsuki S, Bahnson HT (1985) Veno-venous bypass without systemic anticoagulation for transplantation of the human liver. Surg Gynecol Obstetrics 160: 571–572Google Scholar
  9. 9.
    Scherer R, Giebler R, Erhard J, Lange R, Günnicker M, Schmutzler M, Paar D, Kox WJ (1994) A new method of veno-venous bypass during human orthotopic liver transplantation. Anaesthesia 49: 398–402PubMedCrossRefGoogle Scholar
  10. 10.
    Miyamoto Y, Curtiss EJ, Kormos RL, Armitage JM, Hardesty RL, Griffith BP (1990) Bradyarrhythmia after heart transplantation. Incidence, time course, and outcome. Circulation 82 (Suppl): 313–317CrossRefGoogle Scholar
  11. 11.
    DiBiase A, Tse TM, Schnittger I, Wexler L, Stinson EB, Valantine HA (1991) Frequency and mechanism of bradycardia in cardiac transplant recipients and need for pacemakers. Am J Cardiol 67: 1385–1389CrossRefGoogle Scholar
  12. 12.
    Lough ME, Lindsey AD, Shinn JA (1985) Life satisfaction following heart transplantation. Heart Transplant 4: 446–449Google Scholar
  13. 13.
    Lurie KG, Bristow MR, Reitz BA, (1983) Increased beta-adrenergic receptor density in an experimental model of cardiac transplantation. J Thorac Cardio vase Surg 86: 195–201Google Scholar
  14. 14.
    Grattan MT, Moreno-Cabral E, Starnes VA (1989) Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 261: 3561–3566PubMedCrossRefGoogle Scholar
  15. 15.
    Wyner J, Finch E (1987) Heart and heart lung transplantation. In: Gelman S (ed): Anesthesia and Organ Transplantation. WB Saunders Company, Philadelphia, S. 111–137Google Scholar
  16. 16.
    Guilinger RA, Paradis IL, Dauber JH, Yousem SA, Williams PA, Keenan RJ, Griffith BP (1995) The importance of bronchoscopy with transbronchial biopsy and bronchoalveolar lavage in the management of lung transplant recipients. Am J Respir Crit Care Med 152: 2037–2043PubMedGoogle Scholar
  17. 17.
    Griffith BP, Zenati M (1990) The pulmonary donor. Clin Chest Med 11: 217–226PubMedGoogle Scholar
  18. 18.
    Burke CM, Theodore J, Dawkins KD, Yousem SA, Blank N, Billingham ME, van Kessel A, Jamieson SW, Oyer PE, Baldwin JC et al. (1984) Posttransplant obliterative bronchiolitis and other late lung sequelve in human heart-lung transplantation. Chest 86: 824–829PubMedCrossRefGoogle Scholar
  19. 19.
    Starnes VA (1990) Heart - lung transplantation: An overview. Cardiol Clin 8: 159–168PubMedGoogle Scholar
  20. 20.
    Takita K, Goda Y, Kawahigashi H, Okuyama A, Kubota M, Kemmotsu O (1993) Pharmacodynamics of vecuronium in the kidney transplant recipient and the patient with normal renal function. Masui 42: 190–194PubMedGoogle Scholar
  21. 21.
    Valsson F, Ricksten SE, Hedner T, Zall S, William-Olsson EB, Lundin S (1994) Effects of atrial natriuretic peptide on renal function after cardiac surgery and in cyclosporine-treated heart transplant recipients. J Cardiothorac Vase Anesth 8: 425–430CrossRefGoogle Scholar
  22. 22.
    Edwards BS, Lloyd MA, Anderson LM (1993) The synergistic effects of cyclosporine and endothelin - demonstration of an important cardiodepressor action. Transplantation 55: 8–11PubMedCrossRefGoogle Scholar
  23. 23.
    Andreoni KA, O’Donnell CP, Burdick JF, Robotham JL (1994) Hepatic and renal blood flow responses to a clinical dose of intravenous cyclosporine in the pig. Immunopharmacology 28: 87–94PubMedCrossRefGoogle Scholar
  24. 24.
    Sandberg JO, Groth CG, Andersson A, Jansson L (1994) Acute effects of different immunosuppressive drugs on pancreatic, islet, renal, and arterial hepatic blood flow in anaesthetized rats. Transpl Int 7: 319–323PubMedCrossRefGoogle Scholar
  25. 25.
    Ahuja S, Shrivastav S, Danielpour D, Balow J, Boumpas D (1995) Regulation of transforming growth factor–ß1 and its receptor by cyclosporine in human T-lymphocytes. Transplantation 60: 718–723PubMedCrossRefGoogle Scholar
  26. 26.
    Pomer S (1994) Neue immunsuppressive Therapien bei Nierentransplantation. Urologe 33: 370–376PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1996

Authors and Affiliations

  • R. Scherer
  • M. Günnicker
  • J. Erhard

There are no affiliations available

Personalised recommendations